Domů › Rakovina prsu › Arizona › Scottsdale
Klinické studie Rakovina prsu v Scottsdale, AZ
18 studií pro Rakovina prsu hledá účastníky v lokalitách v Scottsdale a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Probíhá náborFáze 2
- Mayo Clinic, Scottsdale
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Probíhá náborFáze 3
- Mayo Clinic, Scottsdale
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Probíhá náborFáze 3
- Ironwood Cancer & Research Centers, Scottsdale
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Probíhá náborFáze 2
- Mayo Clinic in Arizona, Scottsdale
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Probíhá nábor
- Honor Health Research Institute, Scottsdale
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Probíhá náborFáze 3
- Mayo Clinic, Scottsdale
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Probíhá náborFáze 1
- Mayo Clinic of Scottsdale, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Probíhá náborFáze 1
- HonorHealth, Scottsdale
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Probíhá náborFáze 2
- Mayo Clinic in Arizona, Scottsdale
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- HonorHealth Research Institute, Scottsdale
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
Probíhá náborFáze 2
- Mayo Clinic in Arizona, Scottsdale
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Probíhá náborFáze 3
- Mayo Clinic - Scottsdale, Scottsdale
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Probíhá náborFáze 2
- Mayo Clinic - Scottsdale, Scottsdale
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Probíhá náborFáze 3
- Ironwood Cancer & Research Centers, Scottsdale
Cancer Genetic Testing in Ethnic Populations
Probíhá nábor
- Mayo Clinic in Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Probíhá náborFáze 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Scottsdale
Studie Rakovina prsu v jiných městech
- New York City, NY136 studií
- Houston, TX126 studií
- Boston, MA112 studií
- Nashville, TN81 studií
- Los Angeles, CA73 studií
- Edison, NJ68 studií
- St. Louis, MO64 studií
- Queens, NY64 studií
- Durham, NC64 studií
- Chicago, IL59 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
Další studie v Scottsdale
- Rakovina (všechny typy)18 studií
- Metastatický karcinom17 studií
- Rakovina prostaty17 studií
- Kolorektální karcinom16 studií
- Nemalobuněčný plicní karcinom15 studií
- Rakovina slinivky břišní13 studií
- Melanom10 studií
- Ulcerózní kolitida8 studií
- Rakovina plic8 studií
- Rakovina jater (hepatocelulární karcinom)7 studií
- Alzheimerova choroba7 studií
- Trojně negativní rakovina prsu7 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.